Ryan Meacham, MD
Otolaryngology · Portland, ORNPI 1285877316
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations.
Across 81 payments — averaging $20.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$387
- GSK$196
- Optinose US, Inc.$165
- Aerin Medical Inc.$140
- Intersect ENT, Inc.$135
- Regeneron Healthcare Solutions, Inc.$100
- plus $565 from 15 others
What the payments were for
- Food & beverage$1,689100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 17 | $387 |
| GSK | 8 | $196 |
| Optinose US, Inc. | 10 | $165 |
| Aerin Medical Inc. | 8 | $140 |
| Intersect ENT, Inc. | 8 | $135 |
| Regeneron Healthcare Solutions, Inc. | 5 | $100 |
| Johnson & Johnson | 1 | $81 |
| Inspire Medical Systems, Inc. | 4 | $80 |
| Amgen | 4 | $74 |
| Medtronic | 3 | $69 |
| Innovation Technologies Inc | 1 | $43 |
| Merck | 2 | $41 |
| Stryker | 2 | $40 |
| Acclarent, Inc | 1 | $26 |
| Baxter Healthcare | 1 | $21 |
| Medline Industries LP | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Kaleo, Inc. | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Smith+Nephew | 1 | $12 |
How this compares
$1,689 in reported general payments places this provider in the 70th percentile of 128 otolaryngology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Qvar RedihalerBeclomethasone Dipropionate | 11 | $2,388 |
| Ipratropium Bromide | 77 | $1,744 |
| Omeprazole | 63 | $731 |
| Fluticasone Propionate | 16 | $276 |
| Ofloxacin | 13 | $223 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $214 |
| Doxycycline Hyclate | 12 | $199 |
| Pantoprazole Sodium | 37 | $167 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $91 |
| Prednisone | 27 | $83 |
| Diazepam | 12 | $78 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $45 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Portland
- Mathew GeltzeilerPortland$221K
- Ryan LiPortland$160K
- Jeremiah AltPortland$89K
- Mark WaxPortland$20K
- Marcus MonroePortland$16K
- Joshua SchindlerPortland$8K
- Daniel ClayburghPortland$7K
- Timothy HullarPortland$7K
- Paul FlintPortland$7K
- Justin HallPortland$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.